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CLINICAL FEATURES OF BIPOLAR DISORDER
COMORBID WITH ANXIETY DISORDERS DIFFER
BETWEEN MEN AND WOMEN
Erika F. H. Saunders, M.D.,1,2,3∗ Kate D. Fitzgerald, M.D.,2,3 Peng Zhang, M.S.,2,4 and
Melvin G. McInnis, M.D.2,3
Background: Anxiety disorders are commonly comorbid with bipolar disorder
(BP) and may worsen course of illness, but differential impact of specific anx-
iety disorders in men and women remains unknown. Methods: We measured
the impact of comorbid panic disorder (PD), social phobia, specific phobia, and
obsessive-compulsive disorder (OCD) in 460 women and 276 men with Bipo-
lar I Disorder (BPI) or schizoaffective disorder, bipolar type from the National
Institute of Mental Health Bipolar Genetics Initiative. We compared clinical
characteristics in BP with and without each anxiety disorder in men and women
separately correcting for family relatedness. Results: Comorbid PD, OCD, and
specific phobia were more common in women with BP than men. Comorbid so-
cial phobia correlated with increased risk of alcohol abuse in BP women, but
not men. Women with comorbid PD attended fewer years of school. Comorbidity
with OCD was associated with earlier age at the onset of BP for both genders. Co-
morbid PD, OCD, and specific phobia were associated with more antidepressant
trials in BP, across both genders, compared to BP patients without these anxiety
disorders. Conclusion: In BP, comorbid anxiety disorders are associated with
increased risk for functional impairment, and women had differently associated
risks than men. Clinicians should be aware of an increased risk for comorbid PD,
OCD, and specific phobia in women with BP, and an increased risk of alcohol
abuse in women with BD and comorbid social phobia. Depression and Anxiety
29:739–746, 2012. C© 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Anxiety disorders are highly comorbid in bipolar disor-
der (BP), with studies in the National Institute of Mental
Health (NIMH) Bipolar Genetics Initiative sample and
the Systematic Treatment Enhancement Program for
Bipolar Disorder (STEP-BD) cohort showing a higher
incidence of anxiety disorders in patients with BP than
in the general population.[1–6] In BP patients, comor-
bid anxiety disorders have been associated with higher
BP symptom burden and worse severity of illness.[1, 4,7, 8]
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In the general population, anxiety disorders are more
common in women than men, and have been shown to
differentially affect work productivity in women when
compared to men.[3] BP affects men and women at an
equal rate,[4, 9] however, given gender differences in the
presentation of anxiety disorders, there may be specific
features that characterize the association of anxiety dis-
orders in BP women compared to BP men.
In a cross-sectional analysis of the first 500 patients
entered into the STEP-BD cohort, an analysis of gen-
der differences in BP highlighted that women were more
likely than men to be diagnosed with posttraumatic stress
disorder (PTSD), but not other anxiety disorders.[10] In
a study examining the gender differences in the Stanley
Foundation Bipolar Treatment Outcome Network, spe-
cific phobia, obsessive-compulsive disorder (OCD), and
PTSD were more prevalent in women, but not panic dis-
order (PD), agoraphobia without panic, social phobia, or
anxiety not otherwise specified.[11] Women with BP have
also been found to exhibit increased risk for alcoholism
and chronicity of depression, but whether these clinical
correlates of BP in women relate to their increased risk
for anxiety remains to be determined.
Recent cross-sectional studies have shown that anxi-
ety disorder comorbidity affects the clinical presentation
of BP, but a specific relationship by gender was not ex-
plored. Comorbid OCD was associated with a history
of shorter periods of euthymia in the STEP-BD.[1] Sev-
eral studies have reported OCD,[12, 13] PD,[1] and so-
cial phobia to associate with more suicide attempts in
BP,[1, 14,15] although rates differ between studies. In the
STEP-BD cohort, dimensional anxiety scores including
worry, anxiety sensitivity, phobic avoidance, and panic
frequency were linked to increased suicidal ideation and
behavior.[16] Drug and alcohol dependence are also in-
creased in the population of BP patients with anxiety; in
the first 500 STEP-BD patients, having a comorbid anx-
iety disorder doubled the lifetime risk of alcohol abuse
or dependence, and almost doubled the lifetime risk of
substance abuse or dependence.[1] In a sample of BP ado-
lescents, the number of comorbid anxiety disorders in-
crementally increased the risk for substance abuse.[14]
The relationship between comorbid anxiety disorders
and BP has also been examined in prospective studies. In
a study of 138 patients after a 3-year follow-up period,
comorbid social phobia predicted a longer duration of
mood symptoms, and greater illness severity when com-
pared with the group of BP patients without anxiety.[17]
A prospective study that followed the first 1,000 patients
enrolled into the STEP-BD program for 1 year showed
a loss of 29–30 days well for PD; and a loss of 34–44 days
for social phobia and OCD.[7] A report of the Collab-
orative Depression Study describes the relationship be-
tween clinical outcome and anxiety disorder diagnoses
and anxiety symptom clusters in 335 BP patients fol-
lowed for 18.0 years. OCD was found to predict time in
depressive episodes, whereas PD and phobias did not.[8]
The NIMH Bipolar Genetics Initiative dataset is a
large, well-characterized dataset consisting of families
and individuals with BP that includes prevalence of PD,
OCD, social phobia, and specific phobia.[5] In a subset
of BP families from this database, a specific genetic link-
age pattern was described for PD.[18, 19] Further, studies
showed an association between rapid mood switching
and PD in families in this sample.[20, 21] A recent study by
Goes et al.[22] reports on the clinical characteristics and
familial aggregation of anxiety disorders including PD,
OCD, social phobia, and specific phobia in MDD (Ma-
jor Depression Disorder) and BP families from sample,
showing fewer years of education in PD, earlier age of
first depression, higher number of depressive episodes,
and an increased risk of suicide attempt across anxiety
disorders. In that study, comorbid OCD associated with
greater severity, the earliest age of onset for depression,
the earliest age of treatment, and the highest number of
depressive episodes.[22]
To further characterize the clinical features of BP
and comorbid anxiety disorders in men and women, we
queried the clinical features of patients with and with-
out specific anxiety disorders in a sample of 736 partici-
pants diagnosed with BP I and schizoaffective disorder,
BP type derived from the NIMH Bipolar Genetics Ini-
tiative. We examined clinical variables reflecting func-
tional and clinical severity by gender, then identified the
association of the clinical variable to the risk for each
anxiety disorder (PD, OCD, social phobia, specific pho-
bia) in men and women separately. With the exception
of OCD, anxiety disorders are more common in women
in the general population, and we hypothesized that BP
in women would be associated with higher rates of co-
morbid anxiety disorders and that this anxiety would as-
sociate with more impairment in women than men.
METHODS
Gender differences in the prevalence and clinical correlates of
four anxiety disorders (PD, OCD, social phobia, and specific phobia)
were investigated in 736 individuals with BP, type I or schizoaffective
disorder, bipolar type from the NIMH Bipolar Genetics Initiative.
This population was recruited for a study of genetics, and clinical
data were gathered using the Diagnostic Interview for Genetic
Studies (DIGS).[23] In addition to the interview, medical records were
obtained from inpatient and outpatient treatment whenever possible.
A detailed description of methods of assessment and evaluation have
been documented elsewhere.[24] Data were not collected on GAD
(Generalized Anxiety Disorder), PTSD, agoraphobia without panic,
and separation anxiety disorder. The prevalence of PD, OCD, social
phobia, and specific phobia anxiety disorders and the number of
comorbid anxiety disorders were compared between men and women
using χ2 analysis. Clinical variables were compared between genders
using t-tests or Mann-Whitney U tests for continuous variables or χ2
tests for dichotomous variables, as appropriate. Dichotomous clinical
variables included alcohol abuse, alcohol dependence, marital status,
sex, and suicide attempts (yes/no). Continuous clinical variables
included age of BP onset, years of school, number of hospitalizations,
number of manias, number of depressions, severity of depression,
severity of mania, number of antidepressants tried, number of
mood stabilizers tried, number of antipsychotics tried, number of
sedative/hypnotics tried, and number of stimulants tried. The number
of hypomanias was not included due to paucity of data. Quantification
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of severity was determined for the most severe, or most extreme, mood
episode by the interviewer. Anchors for severity included (1) no impair-
ment, (2) improvement in functioning, (3) impairment in functioning,
or (4) incapacitation. Improvement in functioning was defined as an
improvement in occupational or social functioning; improvement can
be associated with hypomania. Impairment was defined as decreased
functioning but not meeting criteria for incapacitation; incapacitation
was defined as an inability to function at home, school, or work for
2 days in a row, hospitalization, ECT treatment, the presence of
psychotic symptoms, or complete inability to carry on a conversation.
Logistic regression models were built using the Generalized Estimat-
ing Equation (GEE) to control for familial relatedness.[25] Each model
was controlled for age at interview. Separate models were built for
PD, OCD, social phobia, and specific phobia. The comparison group
included subjects without each specified anxiety disorder, but included
those with other anxiety disorders. The comparison groups were
chosen this way to allow for detection of differences specific to each
anxiety disorder studied. Predictors that showed significance differ-
ence between groups were included in a refined model, and goodness
of fit was tested using the Quasi Likelihood under Independence
(QIC) Model Criterion to determine the best fitting model. Models
for PD, OCD, social phobia, and specific phobia were then created for
males and females separately to determine the effect of sex on features
of BP with and without anxiety disorders. Because there were only nine
males with comorbid OCD in this sample, the number of clinical pre-
dictors was greater than the number of subjects resulting in insufficient
statistical power; thus, the comparison of models by sex is not included
for OCD.
RESULTS
CHARACTERISTICS OF THE POPULATION
This population of 736 individuals from the NIMH
Bipolar Genetics Initiative represented 473 families.
Almost two thirds of the sample was female (62.5%);
the average age at interview was 42 ± 12 years, and the
average age did not significantly differ between men and
women. One third of the population (N = 242) had one
or more of the four comorbid anxiety disorders—OCD,
PD with and without agoraphobia, social phobia, or
specific phobia. One quarter of the population had one
of these anxiety disorders, and 10% had more than one.
Female subjects with BP were more likely than males to
have one, two, three, or four comorbid anxiety disorders
(χ2 = 16.9, df = 4, P = .002). Table 1 summarizes the
clinical characteristics of the population by gender. A
number of other clinical characteristics also differed
by gender: alcohol dependence was more common in
men than women, whereas suicide attempts, number
of depressive episodes, number of antidepressant treat-
ments, and number of sedative/hypnotic treatments
were greater in women than men.
PANIC DISORDER
The prevalence of comorbid PD in the total sample
was 25%. Three-quarters of the subjects with BP and
PD were women, and the prevalence of comorbid PD
was 30% in women and 17% in men (χ2 = 14.5, df = 1,
P = 1.4 × 10−4). The average age at onset of PD was
24 ± 12 years in the combined sample, and did not
differ between men and women (Table 1). Women are
more likely to have comorbid PD than men (OR = 1.8,
P = .006, 95% CI: 1.2–2.6). Women with BP and PD
were more likely to have fewer years of schooling and
to have used more antidepressants than women with BP
without PD, although this was not true for men with
BP and PD (Table 2). BP subjects with PD were more
likely to have less severe mania than those subjects with
BP without PD (Table 2).
Results of comparisons between BP with PD and BP
without PD were similar in men and women for alco-
hol abuse, alcohol dependence, marital status, suicide
attempts, age of BP onset, number of hospitalizations,
number of manias, number of depressions, severity of
depression, number of mood stabilizers tried, number of
antipsychotics tried, number of sedative/hypnotics tried,
or number of stimulants tried.
OBSESSIVE-COMPULSIVE
DISORDER
The prevalence of comorbid OCD in the sample
was 6%, and 80% of the subjects with BP and OCD
were women. The prevalence of OCD was significantly
greater in women (7%) than in men (3%; χ2 = 4.9,
df = 1, P = .027). The average age at onset of OCD
was 16.2 ± 6.5 years for men and 23.0 ± 13.4 years for
women, which were significantly different (Table 1).
For both male and female patients, comorbid OCD
was associated with lower age at onset of BP and more
antidepressant treatment than in those without OCD
(Table 2). Other clinical covariates including alcohol
abuse, alcohol dependence, marital status, suicide
attempts, years of school, number of hospitalizations,
number of manias, number of depressions, severity
of depression, severity of mania, number of mood
stabilizers tried, number of antipsychotics tried, number
of sedative/hypnotics tried, and number of stimulants
tried were not significantly different between those with
BP and comorbid OCD and BP without OCD. We
choose not to do an analysis of BP comorbid with OCD
by gender because only a few men with comorbid BP
and OCD were observed in our sample.
SOCIAL PHOBIA
Comorbid social phobia was prevalent at a rate of
8%, and 63% of those with social phobia and BP were
women. The prevalence of social phobia did not differ
significantly between men and women (χ2 = .033, df = 1,
P = .856). The average age at onset of social phobia was
13 ± 8 years and did not differ significantly between
men and women (Table 1). Women with BP and social
phobia were four times more likely than women with-
out comorbid social phobia to have comorbid alcohol
abuse. Men with social phobia were not more likely to
have alcohol abuse than men without comorbid social
phobia. Other clinical characteristics including alcohol
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TABLE 1. Clinical characteristics of the sample by gender; comparisons between males and females
Total Female Male
N = 736 N = 460 (62.5%) N = 276 (37.5%)
Number of comorbid anxiety disorders N (% of total)*
0 494 (67%) 286 (39%) 208 (28%)
1 165 (22%) 115 (25%) 50 (18%)
2 58 (8%) 42 (9%) 16 (6%)
3 15 (2%) 14 (3%) 1 (.4%)
4 4 (.5%) 3 (.7%) 1 (.4%)
Age at interview (y) 42.6 ± 12.4 42.9 ± 12.0 42.1 ± 13.1
Age at onset BP (y) 20.0 ± 8.8 19.6 ± 8.8 20.7 ± 8.9
Age at first treatment (y) 22.8 ± 9.0 22.9 ± 8.7 23.0 ± 9.8
Age at onset PD 24.4 ± 11.8 24.8 ± 12.1 23.3 ± 10.7
Age at onset OCD* 21.5 ± 12.5 23.0 ± 13.4 16.2 ± 6.5
Age at onset Social Phobia 12.9 ± 7.9 12.0 ± 8.6 14.6 ± 6.5
Age at onset Specific phobia* 11.0 ± 8.3 12.0 ± 8.8 7.3 ± 4.4
Alcohol abuse 45 (6.5%) 31 (6.7%) 18 (6.5%)
Alcohol dependence** 221 (30.7%) 107 (23.3%) 116 (42.0%)
Married 319 (43.9%) 202 (43.9%) 121 (43.8%)
Number of years of school 14 ± 3 14.2 ± 2.6 14.5 ± 2.9
Suicide attempt** 310 (43.1%) 225 (48.9%) 89 (32.2%)
Severity of mania 2.8 ± .55 2.8 ± .58 2.8 ± .50
Severity of depression 1.8 ± .46 1.8 ± .43 1.8 ± .50
Number of manias 11.0 ± 27.3 11.2 ± 29.4 10.3 ± 22.4
Number of depressions* 13.7 ± 31.4 15.5 ± 34.8 10.3 ± 23.3
Number of psych hospitalizations 5.3 ± 8.3 5.5 ± 9.4 5.0 ± 6.1
Number of antidepressants** 3.1 ± 2.7 3.4 ± 2.8 2.6 ± 2.4
Number of mood stabilizers 1.6 ± .88 1.6 ± .91 1.6 ± .83
Number of antipsychotics 1.6 ± 1.8 1.7 ± 1.8 1.6 ± 1.7
Number of sedative/hypnotics** 1.6 ± 1.9 1.8 ± 2.0 1.3 ± 1.7
Number of stimulants .09 ± .31 .08 ± .28 .11 ± .35
*P < .05; **P < .01.
dependence, marital status, suicide attempts, age of BP
onset, years of school, number of hospitalizations, num-
ber of manias, number of depressions, severity of depres-
sion, severity of mania, number of antidepressants tried,
number of mood stabilizers tried, number of antipsy-
chotics tried, number of sedative/hypnotics tried, and
number of stimulants tried were not significantly differ-
ent between those with BP and social phobia and those
without social phobia, and results of these comparisons
did not significantly differ between men and women.
SPECIFIC PHOBIA
Comorbid specific phobia was prevalent at a rate
of 8%, and 81% of the subjects with BP and specific
phobia were women. Prevalence of comorbid specific
phobia differed significantly between women (10%) and
men (4%; χ2 = 8.6, df = 1, P = .005). The average
age at onset of specific phobia was 11 ± 8 years, and
was significantly less in men (7.3 ± 4.4) than in women
(12.0 ± 8.8). Women with comorbid specific phobia
were more likely to have had more treatment with
antidepressants and were less likely to have had sedative
hypnotics than BP subjects without social phobia
(Table 2). Other clinical characteristics including alco-
hol abuse, alcohol dependence, marital status, suicide
attempts, age of BP onset, years of school, number of
hospitalizations, number of manias, number of depres-
sions, severity of depression, severity of mania, number
of mood stabilizers tried, number of antipsychotics
tried, number of sedative/hypnotics tried, and number
of stimulants tried were not significantly different
between those with BP and specific phobia and those
without specific phobia, and did not significantly differ
between men and women.
DISCUSSION
We examined differences in the prevalence of co-
morbid PD, OCD, social phobia, and specific phobia
between men and women with BP, and compared
differences in clinical features of BP with and without
each comorbid anxiety disorder in men and women.
Female gender increased the odds of having comorbid
PD, OCD, and specific phobia, but not social phobia,
consistent with increased rates of anxiety disorders in
women in the general population.[3, 26] Studies of gender
differences in BP have shown variable results with regard
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TABLE 2. Odds ratios for predictors of comorbid anxiety disorders in BP. All analyses corrected for age at interview
and family relatedness
Panic OCD Social phobia Specific phobia
N N N N
N (% of total sample) 186 (25%) 42 (6%) 55 (8%) 59 (8%)
F (% of all F) 138 (30%)** 33 (7%)* 35 (8%) 47 (10%)**
M (% of all M) 48 (17%) 9 (3%) 20 (7%) 12 (4%)
OR 95%CI OR 95% CI OR 95% CI OR 95% CI
Female 1.8 1.2–2.6 1.9 .87–4.2 .98 .55–1.8 2.7 1.4–5.0
Alcohol abuse 1.6 .86–3.1 2.4 .97–5.9 2.8 1.3–6.0 .65 .18–2.4
Male .79 .17–3.7 *** 1.4 .30–6.2 1.5 .24–9.8
Female 1.8 .82–3.9 4.1 1.7–9.9 .31 .04–2.7
Schooling .90 .83–.96 .92 .82–1.0 .99 .89–1.1 .93 .84–1.0
Male .92 .97–1.2 *** .98 .82–1.2 1.0 .79–1.3
Female .89 .82–.97 1.0 .84–1.2 .93 .83–1.1
Age at onset BP .98 .95–1.0 .94 .90–.99 .98 .94–1.0 1.0 .95–1.1
Male .97 .93–1.0 *** 1.0 .98–1.0 .99 .87–1.1
Female .99 .96–1.0 .97 .93–1.0 1.0 .96–1.1
Severity of mania .64 .42–.97 .88 .57–1.3 .74 .44–1.3 .74 .34–1.4
Male .78 .47–1.3 *** 2.7 .66–11.1 .62 .26–1.5
Female .78 .55–1.1 .72 .39–1.3 .65 .40–1.1
Antidepressant treatments 1.1 1.1–1.2 1.1 1.0–1.3 1.0 .91–1.2 1.2 1.1–1.3
Male 1.1 .97–1.2 *** 1.1 .84–1.4 1.1 .79–1.5
Female 1.1 1.1–1.2 1.2 .96–1.4 1.2 1.1–1.4
Sedative/hypnotic treatments 1.1 .96–1.2 .93 .77–1.1 1.1 .48–2.5 .76 .62–.94
Male 1.1 .96–1.3 1.1 .80–1.5 .68 .41–1.1
Female 1.0 .91–1.2 1.0 .79–1.2 .78 .62–.97
*P < .05; **P < .01; ***analysis by sex not valid in OCD due to small number of men in the sample.
Note: Bold = P < 0.028.
to increased rates of anxiety disorders; Altshuler et al.[11]
showed elevated rates in women of specific phobia and
OCD but not PD or social phobia; and Baldassano
et al.[10] showed no increase in PD, social phobia, or
OCD in women. One difference in our study is that
the sample consisted of families with BP; PD and OCD
were shown in this sample to aggregate in families,[22]
and women with familial BP may be more prone to
comorbid anxiety disorders.
Increased rates of anxiety disorders in BP may be
linked to an underlying predilection for trait anxiety,
since high neuroticism has been linked to BP and pre-
disposes to anxiety, particularly in women.[27–30] Neu-
roticism also predisposes to depression, however, we did
not find an increase in number or severity of depressive
episodes in this sample, consistent with the STEP-BD
data.[10] This may be due to the retrospective nature of
our data and quantifying depression by the number of
episodes, as a prospective study has shown that women
had no more episodes than men but had more depressive
symptoms on follow-up.[11] However, although we also
did not find a difference in severity of the worst depres-
sive or manic episode by gender, this measurement does
not give an indication of chronicity of the symptoms, and
it is possible that such a measure would show a difference
by gender.
Women in this sample demonstrated an elevated rate
of alcohol abuse with respect to the general population,
consistent with a number of studies.[10, 31,32] In addi-
tion, women with comorbid social phobia demonstrated
a four-fold increased risk for alcohol abuse, whereas risk
was not increased by social phobia for men. The im-
pulsivity seen in manic and hypomanic episodes may
increase the likelihood of binge drinking in women
with BP and social phobia, who may be particularly
likely to use alcohol to facilitate social interaction. Un-
derstanding the interaction of these comorbidities will
underscore the need for clinicians to be attentive to
the possibility of binge drinking in women with BP
and social phobia, increasing the likelihood of early
intervention.
We find that patients with comorbid PD have fewer
years of school, and this difference is significant in
women but not men. Educational impairment in women
with BP with comorbid PD could be driven by the onset
of PD, since the age of onset of PD was in the early 20s;
symptoms experienced prior to the onset of the full dis-
order could contribute to dropping out more frequently
from school. Female patients with PD have been shown
to have more respiratory symptoms than men, have ab-
normal respiratory physiology, and are more sensitive
to CO2 induction of panic attacks.[33, 34] The type of PD
found in women with BP may differ in severity from men
and lead to more functional impairment.
OCD was associated with an earlier age at onset of
BP, raising the concern that OCD itself or its treatment
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(e.g. with selective serotonin reuptake inhibitors) might
induce mania in individuals with a BP diathesis. How-
ever, the average age at the onset of OCD was 2 years
after the average age at onset of BP for the combined
sample, so that most subjects in this sample would not
have been treated for OCD prior to developing BP. The
age of onset was significantly higher in women, and lower
in men, however, the sample size for men with comorbid
OCD was small and this difference could be skewed. In
addition, comorbidity with OCD did not affect the age
at the first treatment, which did not differ between men
and women, thus it is unlikely the pharmacological inter-
vention for OCD could have induced BP. Another pos-
sibility is that BP with comorbid OCD may be a unique,
earlier occurring subtype with a common or overlapping
biological etiology. For instance, striatal hyperactivity
has been demonstrated in both OCD and BP raising the
possibility of a common etiological basis.[35, 36]
Comorbid social phobia and specific phobia preceded
BP in subjects with both disorders, but was not associ-
ated with a lower age of onset of BP. Comorbid specific
phobia was found to be present much earlier in men
than women, but there were no other clinical character-
istics that were more severe in the male patients with BP
and specific phobia than in the female patients. In fact,
women with BP and specific phobia had a history of more
treatments with antidepressants and sedative/hypnotics
than men.
Despite the early age of onset of social phobia
(13 years in our sample of BPI), age at the first psychi-
atric treatment was not significantly different between
the individuals with social phobia and those without, in-
dicating that social phobia was untreated prior to the
development of mood symptoms, and that BP was not
antidepressant driven. Comorbid social phobia was the
only anxiety comorbidity investigated that did not have a
predominance of antidepressant use in females, perhaps
reflecting the equal gender distribution of comorbid so-
cial phobia. Given the prevalent comorbidity of social
phobia and BP, and the fact that there were on aver-
age 9 years between the onset of social phobia and BP,
these data would suggest the importance of heightened
awareness of early social phobia in both men and women
with BP.
Several anxiety comorbidities were associated with in-
creased number of antidepressants trials including OCD,
specific phobia, and PD, and results in PD and specific
phobia were driven by increased antidepressant use in
women. Data from the STEP-BD cohort showed no
overall difference in antidepressant use in women when
compared to men,[10] however in an analysis that com-
bined genders, comorbid PD and social anxiety disorder
increased the likelihood that subjects were taking an-
tidepressants at the start of the study.[37] Interestingly,
in that study cohort, the odds ratio of antidepressant
use for OCD was not significantly higher than for those
without OCD. The increased number of antidepressants
over a lifetime in women with comorbid PD and spe-
cific phobia, and in men and women with comorbid
OCD may be an indicator of severity, may signal that
anxiety was not responsive to antidepressants, or that
certain antidepressants were associated with intolerable
side effects, including switching to hypomanic or manic
states. Preliminary research suggests that comorbid anx-
iety disorders may render BP refractory to treatment,
possibly due to the hypomanic switches induced when
serotonergic medications are prescribed for anxiety
symptoms.[38]
Our study is limited by the cross-sectional nature
of the evaluations, the limited information we have on
treatment, and lack of information on several important
anxiety disorders including PTSD, GAD, agoraphobia
without panic, and separation anxiety disorder. For this
reason, we were unable to compare those with anxiety to
those without anxiety disorder at all; to account for this,
we compared BP with and without each disorder indi-
vidually. Because these disorders may be present in the
“non-anxiety” group in these data, the comparisons be-
tween the anxiety disorder groups and the group without
each of the studied anxiety disorders may be attenuated.
PTSD and GAD in particular have been associated with
worsened course of illness and severity of BP;[7, 17] thus,
individuals with PTSD and GAD who were accounted
for in the “non-anxiety” group might have a more severe
BP, which lessens the differences in comparison with the
anxiety disorder group. Our results therefore can be in-
terpreted to be specific to the comorbid anxiety disorders
studied here.
In addition, all of the data were gathered retrospec-
tively, and recollection bias could impact the recall of
symptoms that occurred many years ago. Whenever pos-
sible, information from medical records was used to cor-
roborate recall, however, this was not possible in all cases.
Future investigation should include measures of neu-
roticism in studies to evaluate the interaction between
gender, personality features, and development of mood
and anxiety disorders. Additionally, longitudinal studies
of youth at risk for BP will begin to disentangle the
possible interplay between mood and anxiety symptoms
over the course of development in girls and boys. In
clinical samples of anxious youth, separation anxiety
disorder tends to precede the development of PD,[39]
the most prevalent comorbid anxiety disorder in our
sample of adult subjects with BP. In addition, early onset
anxiety symptoms may commingle across the anxiety
disorders, such that children with separation anxiety
disorder, GAD, PD, or OCD are likely to develop any
of the others at a 2-year follow-up.[40] Given the age at
interview of subjects included in our study, it is possible
that early childhood anxiety symptoms may have been
lost due to recollection bias.
Our work highlights the risk for comorbid anxiety dis-
orders in women with BP, and the finding that a num-
ber of measures of severity are differentially affected in
women with anxiety comorbities than those without.
Taken together, these findings support early attention
to anxiety disorders in the treatment of women with BP
to improve clinical care.
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